RAPT Therapeutics, Inc. (RAPT) Return on Equity (2020 - 2024)
RAPT Therapeutics' Return on Equity history spans 5 years, with the latest figure at 1.12% for Q3 2024.
- For Q3 2024, Return on Equity fell 49.0% year-over-year to 1.12%; the TTM value through Sep 2024 reached 1.12%, down 49.0%, while the annual FY2023 figure was 0.65%, 25.0% down from the prior year.
- Return on Equity for Q3 2024 was 1.12% at RAPT Therapeutics, down from 1.07% in the prior quarter.
- Across five years, Return on Equity topped out at 0.3% in Q3 2021 and bottomed at 1.12% in Q3 2024.
- The 5-year median for Return on Equity is 0.45% (2020), against an average of 0.57%.
- The largest annual shift saw Return on Equity increased 16bps in 2022 before it tumbled -57bps in 2024.
- A 5-year view of Return on Equity shows it stood at 0.48% in 2020, then rose by 28bps to 0.34% in 2021, then fell by -15bps to 0.39% in 2022, then crashed by -101bps to 0.79% in 2023, then crashed by -41bps to 1.12% in 2024.
- Per Business Quant, the three most recent readings for RAPT's Return on Equity are 1.12% (Q3 2024), 1.07% (Q2 2024), and 0.92% (Q1 2024).